Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 6, 2011, Pages 573-583

  Hübner, Melanie ^a   Dizayee, Sara ^b   Matthes, Jan ^b   Seifert, Roland ^c   Herzig, Stefan ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AC inhibition; Cardiomyocytes; Isoproterenol; L type calcium current; MANT nucleotides; Whole cell patch clamp

Indexed keywords

2'(3') METHYLANTHRANILOYL ADENOSINE 5' TRIPHOSPHATE; 2'(3') METHYLANTHRANILOYL GUANOSINE 5' [GAMMA THIO]TRIPHOSPHATE; 2'(3') METHYLANTHRANILOYL INOSINE 5' TRIPHOSPHATE; 2'(3') METHYLANTHRANILOYL NUCLEOSIDE 5' [GAMMA THIO]TRIPHOSPHATE; ADENYLATE CYCLASE INHIBITOR; CALCIUM CHANNEL L TYPE; ISOPRENALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STABILITY; ENZYME INHIBITION; HEART MUSCLE CELL; HEART VENTRICLE; MOUSE; NONHUMAN; PATCH CLAMP; SIGNAL TRANSDUCTION; WHOLE CELL;

ADENYLATE CYCLASE; ANIMALS; CALCIUM CHANNELS, L-TYPE; ENZYME INHIBITORS; INOSINE NUCLEOTIDES; INOSINE TRIPHOSPHATE; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79959373119     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0626-x     Document Type: Article

References (33)

1. 2+-channels: implications for fibrosis and heart rate in mice Cardiovasc Res 84 396 406 10.1093/cvr/cvp251 1:CAS:528:DC%2BD1MXhsVGnurvF
2. Chester JA and Watts VJ (2007) Adenylyl cyclase 5: a new clue in the search for the "fountain of youth"? Sci STKE 2007:pe64.
3. N Defer M Best-Belpomme J Hanoune 2000 Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase Am J Physiol Ren Physiol 279 F400 F416 1:CAS:528:DC%2BD3cXmvFSjs7g%3D
4. CW Dessauer JJ Tesmer SR Sprang AG Gilman 1999 The interactions of adenylate cyclases with P-site inhibitors Trends Pharmacol Sci 20 205 210 10.1016/S0165-6147(99)01310-3 1:CAS:528:DyaK1MXksVent7c%3D (Pubitemid 29249055)
5. F Eckstein 2000 Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev 10 117 121 10.1089/oli.1.2000.10.117 1:CAS:528:DC%2BD3cXivVKltL8%3D (Pubitemid 30255596)
6. R Fischmeister LR Castro A Abi-Gerges F Rochais J Jurevicius J Leroy G Vandecasteele 2006 Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases Circ Res 99 8 816 828 10.1161/01.RES.0000246118.98832.04 1:CAS:528:DC%2BD28XhtVKjtL%2FP (Pubitemid 44556380)
7. MD Fuller MA Emrick M Sadilek T Scheuer WA Catterall 2010 Molecular mechanism of calcium channel regulation in the fight-or-flight response Sci Signal 3 141 ra70 10.1126/scisignal.2001152
8. A Gille R Seifert 2003 2′(3′)-O-(N-methylanthraniloyl)- substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors J Biol Chem 278 12672 12679 10.1074/jbc.M211292200 1:CAS:528:DC%2BD3sXislGrs7s%3D (Pubitemid 36800027)
9. A Gille R Seifert 2003 MANT-substituted guanine nucleotides: a novel class of potent adenylyl cyclase inhibitors Life Sci 74 271 279 10.1016/j.lfs.2003.09.014 1:CAS:528:DC%2BD3sXos12qt7Y%3D (Pubitemid 37357058)
10. A Gille GH Lushington TC Mou MB Doughty RA Johnson R Seifert 2004 Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides J Biol Chem 279 19955 19969 10.1074/jbc.M312560200 1:CAS:528:DC%2BD2cXjs1Whsr0%3D (Pubitemid 38623438)
11. M Göttle J Geduhn B König A Gille K Höcherl R Seifert 2009 Characterization of mouse heart adenylyl cyclase J Pharmacol Exp Ther 329 1156 1165 10.1124/jpet.109.150953
12. J Hanoune N Defer 2001 Regulation and role of adenylyl cyclase isoforms Annu Rev Pharmacol Toxicol 41 145 174 10.1146/annurev.pharmtox.41.1.145 1:CAS:528:DC%2BD3MXjsVaqsbY%3D (Pubitemid 32385886)
13. 2+ current in single heart cells Nature 323 273 275 10.1038/323273a0 1:CAS:528:DyaL28XlvVCls7c%3D (Pubitemid 16054316)
14. T Hiratsuka 1983 New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes Biochim Biophys Acta 742 496 508 10.1016/0167-4838(83)90267-4 1:CAS:528:DyaL3sXhsFKqtLY%3D (Pubitemid 13154050)
15. JD Johnson JD Walters JS Mills 1987 A continuous fluorescence assay for cyclic nucleotide phosphodiesterase hydrolysis of cyclic GMP Anal Biochem 162 291 295 10.1016/0003-2697(87)90039-X 1:CAS:528:DyaL2sXksleis7Y%3D (Pubitemid 17064328)
16. SM Lohmann R Fischmeister U Walter 1991 Signal transduction by cGMP in heart Basic Res Cardiol 86 503 514 10.1007/BF02190700 1:STN:280: DyaK387ltlWlsA%3D%3D
17. MJ Lohse S Engelhardt T Eschenhagen 2003 What is the role of β-adrenergic signaling in heart failure? Circ Res 93 896 906 10.1161/01.RES.0000102042.83024.CA 1:CAS:528:DC%2BD3sXoslykurk%3D (Pubitemid 37433227)
18. TC Mou A Gille DA Fancy R Seifert SR Sprang 2005 Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N- Methylanthraniloyl)-guanosine 5′-triphosphate J Biol Chem 280 7253 7261 10.1074/jbc.M409076200 1:CAS:528:DC%2BD2MXhsFSjsrw%3D (Pubitemid 40341283)
19. TC Mou A Gille S Suryanarayana M Richter R Seifert SR Sprang 2006 Broad specificity of mammalian adenylyl cyclase for interaction with 2′,3′-substituted purine- and pyrimidine nucleotide inhibitors Mol Pharmacol 70 878 886 10.1124/mol.106.026427 1:CAS:528:DC%2BD28Xps1SmsLo%3D (Pubitemid 44268445)
20. M Newton I Niewczas J Clark TC Bellamy 2010 A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase Anal Biochem 402 129 136 10.1016/j.ab.2010.03.041 1:CAS:528:DC%2BC3cXmsVCqs7w%3D
21. Q Ni J Shaffer JA Adams 2000 Insights into nucleotide binding in protein kinase A using fluorescent adenosine derivatives Protein Sci 9 1818 1827 10.1110/ps.9.9.1818 1:CAS:528:DC%2BD3cXntFamsLk%3D
22. S Okumura G Takagi J Kawabe G Yang MC Lee C Hong J Liu DE Vatner J Sadoshima SF Vatner, et al. 2003 Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload Proc Natl Acad Sci USA 100 9986 9990 10.1073/pnas.1733772100 1:CAS:528:DC%2BD3sXmvVeisr8%3D (Pubitemid 37087055)
23. S Okumura S Suzuki Y Ishikawa 2009 New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene J Pharmacol Sci 109 354 359 10.1254/jphs.08R26FM 1:CAS:528:DC%2BD1MXktVSqurc%3D
24. 2+ current in guinea-pig ventricular cells J Physiol 443 387 404 1:CAS:528:DyaK3MXmt1Cntr4%3D
25. S Pierre T Eschenhagen G Geisslinger K Scholich 2009 Capturing adenylyl cyclases as potential drug targets Nat Rev Drug Discov 8 4 321 335 10.1038/nrd2827 1:CAS:528:DC%2BD1MXjvV2ksL0%3D
26. C Pinto D Papa M Hübner TC Mou GH Lushington R Seifert 2008 Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs J Pharmacol Exp Ther 325 27 36 10.1124/jpet.107.131904 1:CAS:528: DC%2BD1cXktFGjt7w%3D (Pubitemid 351439155)
27. C Pinto M Hübner A Gille M Richter TC Mou SR Sprang R Seifert 2009 Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs Biochem Pharmacol 78 62 69 10.1016/j.bcp.2009.03.023 1:CAS:528:DC%2BD1MXmtVKksro%3D
28. AE Remmers 1998 Detection and quantitation of heterotrimeric G proteins by fluorescence resonance energy transfer Anal Biochem 257 89 94 10.1006/abio.1997.2533 1:CAS:528:DyaK1cXhsF2msbY%3D (Pubitemid 28117347)
29. F Rochais A Abi-Gerges K Horner F Lefebvre DM Cooper M Conti R Fischmeister G Vandecasteele 2006 A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes Circ Res 98 8 1081 1088 10.1161/01.RES.0000218493. 09370.8e 1:CAS:528:DC%2BD28Xjs1Kltro%3D
30. D Rottländer J Matthes SF Vatner R Seifert S Herzig 2007 Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2′(3′)-O-(N- methylanthraniloyl)-guanosine 5′-[γ-thio]triphosphate J Pharmacol Exp Ther 321 608 615 10.1124/jpet.106.118422 (Pubitemid 46624491)
31. R Sadana CW Dessauer 2009 Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies Neurosignals 17 5 22 10.1159/000166277 1:CAS:528:DC%2BD1MXhslyit78%3D
32. HM Taha J Schmidt M Göttle S Suryanarayana Y Shen WJ Tang A Gille J Geduhn B König S Dove, et al. 2009 Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2′(3′)-O-(N- (methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides Mol Pharmacol 75 693 703 10.1124/mol.108.052340 1:CAS:528:DC%2BD1MXis1ajs7o%3D
33. L Yan DE Vatner JP O'Connor A Ivessa H Ge W Chen S Hirotani Y Ishikawa J Sadoshima SF Vatner 2007 Type 5 adenylyl cyclase disruption increases longevity and protects against stress Cell 130 247 258 10.1016/j.cell.2007.05.038 1:CAS:528:DC%2BD2sXovFalt78%3D (Pubitemid 47081133)